« VirtualLogix raises $16,000,000
Tevet Process Control Technologies raises $27,500,000 »

Agensys raises $41,300,000

July 12, 2007
 VCA Theme: Biological Therapeutics

Agensys, Inc., a privately held biotechnology company, today announced that it has raised $41.3 million through a Series D financing Agensys, Inc. is a privately held biotechnology company that is developing a pipeline of therapeutic monoclonal antibodies (MAbs) to treat solid tumor cancers.